Real-time
Borsa Italiana
08:06:42 30/04/2024 pm IST
|
5-day change
|
1st Jan Change
|
50.1
EUR
|
+1.38%
|
|
-4.75%
|
+2.60%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,667
|
9,330
|
11,657
|
7,959
|
10,042
|
10,172
|
-
|
-
|
Enterprise Value (EV)
1 |
8,570
|
10,195
|
12,405
|
9,379
|
11,621
|
11,478
|
11,246
|
11,048
|
P/E ratio
|
21.3
x
|
26.7
x
|
30.6
x
|
25.9
x
|
26.2
x
|
22.1
x
|
19.8
x
|
18.8
x
|
Yield
|
2.66%
|
2.32%
|
1.95%
|
2.97%
|
2.46%
|
2.85%
|
3.13%
|
3.39%
|
Capitalization / Revenue
|
5.17
x
|
6.44
x
|
7.38
x
|
4.29
x
|
4.82
x
|
4.43
x
|
4.17
x
|
3.99
x
|
EV / Revenue
|
5.78
x
|
7.04
x
|
7.85
x
|
5.06
x
|
5.58
x
|
4.99
x
|
4.61
x
|
4.33
x
|
EV / EBITDA
|
15.8
x
|
17.9
x
|
20.6
x
|
13.9
x
|
15.1
x
|
13.6
x
|
12.6
x
|
11.7
x
|
EV / FCF
|
28.3
x
|
26.7
x
|
26.4
x
|
21.4
x
|
25.5
x
|
23.9
x
|
21
x
|
18.3
x
|
FCF Yield
|
3.53%
|
3.75%
|
3.79%
|
4.68%
|
3.92%
|
4.19%
|
4.76%
|
5.47%
|
Price to Book
|
6.45
x
|
7.33
x
|
8.42
x
|
5.15
x
|
6.06
x
|
5.26
x
|
5.24
x
|
4.96
x
|
Nbr of stocks (in thousands)
|
2,04,070
|
2,05,817
|
2,06,325
|
2,05,406
|
2,05,645
|
2,05,821
|
-
|
-
|
Reference price
2 |
37.57
|
45.33
|
56.50
|
38.75
|
48.83
|
49.42
|
49.42
|
49.42
|
Announcement Date
|
14/02/20
|
22/02/21
|
24/02/22
|
21/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,482
|
1,449
|
1,580
|
1,853
|
2,082
|
2,298
|
2,437
|
2,552
|
EBITDA
1 |
544
|
569.3
|
602.3
|
672.8
|
769.6
|
846.3
|
893.8
|
940.5
|
EBIT
1 |
465.3
|
469
|
490.2
|
437.3
|
558
|
682.2
|
742.5
|
777.1
|
Operating Margin
|
31.4%
|
32.37%
|
31.02%
|
23.6%
|
26.8%
|
29.68%
|
30.47%
|
30.45%
|
Earnings before Tax (EBT)
1 |
444.1
|
455.7
|
463.4
|
401.4
|
491
|
585.8
|
659.8
|
711.6
|
Net income
1 |
368.8
|
355
|
386
|
312.3
|
389.2
|
477.4
|
523
|
552
|
Net margin
|
24.89%
|
24.5%
|
24.43%
|
16.85%
|
18.69%
|
20.77%
|
21.46%
|
21.63%
|
EPS
2 |
1.764
|
1.698
|
1.846
|
1.494
|
1.861
|
2.236
|
2.490
|
2.627
|
Free Cash Flow
1 |
302.8
|
382.3
|
469.8
|
439
|
456
|
480.5
|
535.4
|
603.9
|
FCF margin
|
20.43%
|
26.39%
|
29.73%
|
23.69%
|
21.9%
|
20.9%
|
21.97%
|
23.66%
|
FCF Conversion (EBITDA)
|
55.65%
|
67.15%
|
78%
|
65.25%
|
59.25%
|
56.77%
|
59.9%
|
64.21%
|
FCF Conversion (Net income)
|
82.09%
|
107.69%
|
121.71%
|
140.57%
|
117.16%
|
100.65%
|
102.36%
|
109.4%
|
Dividend per Share
2 |
1.000
|
1.050
|
1.100
|
1.150
|
1.200
|
1.407
|
1.547
|
1.677
|
Announcement Date
|
14/02/20
|
22/02/21
|
24/02/22
|
21/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
---|
Net sales
|
760.2
|
770.8
|
385.4
|
423.9
|
419.4
|
473.1
|
892.5
|
485.1
|
475.8
|
551.4
|
492.9
|
1,044
|
511.9
|
526.1
|
-
|
EBITDA
1 |
311.1
|
300.5
|
147.4
|
154.4
|
163
|
171.8
|
334.9
|
181.3
|
156.6
|
220.8
|
185.4
|
406.2
|
189.4
|
174
|
241.6
|
EBIT
|
261.5
|
250.4
|
122.6
|
117.3
|
131.3
|
101
|
232.3
|
123.6
|
81.42
|
172.6
|
165.6
|
338.2
|
100.6
|
119.2
|
-
|
Operating Margin
|
34.4%
|
32.49%
|
31.8%
|
27.66%
|
31.3%
|
21.35%
|
26.03%
|
25.48%
|
17.11%
|
31.3%
|
33.6%
|
32.39%
|
19.65%
|
22.66%
|
-
|
Earnings before Tax (EBT)
|
254.4
|
235.5
|
115.2
|
112.7
|
124.3
|
69.83
|
194.2
|
115.6
|
91.72
|
159.9
|
128.9
|
288.9
|
100.8
|
101.3
|
-
|
Net income
1 |
196.9
|
207.1
|
89.28
|
89.61
|
96.72
|
54.68
|
151.4
|
90.05
|
70.84
|
124
|
103.6
|
227.6
|
76.9
|
84.7
|
132
|
Net margin
|
25.9%
|
26.87%
|
23.17%
|
21.14%
|
23.06%
|
11.56%
|
16.96%
|
18.57%
|
14.89%
|
22.48%
|
21.03%
|
21.79%
|
15.02%
|
16.1%
|
-
|
EPS
2 |
0.9420
|
0.9900
|
0.4270
|
0.4290
|
0.4620
|
0.2620
|
-
|
0.4310
|
0.3390
|
0.5930
|
0.4950
|
-
|
0.3680
|
-
|
0.6300
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
30/07/20
|
29/07/21
|
28/10/21
|
24/02/22
|
10/05/22
|
28/07/22
|
28/07/22
|
08/11/22
|
21/02/23
|
11/05/23
|
28/07/23
|
28/07/23
|
07/11/23
|
22/02/24
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
903
|
866
|
748
|
1,420
|
1,579
|
1,306
|
1,074
|
876
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.659
x
|
1.521
x
|
1.241
x
|
2.11
x
|
2.052
x
|
1.543
x
|
1.202
x
|
0.9314
x
|
Free Cash Flow
1 |
303
|
382
|
470
|
439
|
456
|
480
|
535
|
604
|
ROE (net income / shareholders' equity)
|
34.1%
|
28.7%
|
32%
|
32.3%
|
32.5%
|
29.4%
|
33.1%
|
34.8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
15.4%
|
9.17%
|
9.49%
|
14%
|
13.9%
|
14.2%
|
Assets
1 |
-
|
-
|
2,512
|
3,407
|
4,103
|
3,398
|
3,757
|
3,879
|
Book Value Per Share
2 |
5.830
|
6.190
|
6.710
|
7.530
|
8.060
|
9.400
|
9.430
|
9.970
|
Cash Flow per Share
2 |
1.630
|
1.960
|
2.350
|
2.210
|
2.320
|
3.210
|
1.840
|
3.180
|
Capex
1 |
31.3
|
21.3
|
21.9
|
23.9
|
380
|
75.8
|
82.2
|
72.6
|
Capex / Sales
|
2.11%
|
1.47%
|
1.38%
|
1.29%
|
18.23%
|
3.3%
|
3.37%
|
2.85%
|
Announcement Date
|
14/02/20
|
22/02/21
|
24/02/22
|
21/02/23
|
22/02/24
|
-
|
-
|
-
|
Last Close Price
49.42
EUR Average target price
52.14
EUR Spread / Average Target +5.50% Consensus |
1st Jan change
|
Capi.
|
---|
| +2.60% | 10.9B | | +35.91% | 664B | | +29.95% | 567B | | -7.13% | 354B | | +19.81% | 330B | | +4.57% | 286B | | +13.58% | 234B | | +5.34% | 199B | | -9.82% | 196B | | -4.80% | 148B |
Other Pharmaceuticals
|